Kai Chio Chan

ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression

Neil G. Anderson, Tawhid Ahmad, Kai Chio Chan et al. · International Journal of Cancer · 2001 · 195 citations

Medicine, Oncology, Pharmacology +17

Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma <i>in situ</i> after breast-conserving surgery

G.P. Boland, Kai Chio Chan, W.F. Knox et al. · British journal of surgery · 2003 · 95 citations · Full text

Medicine, Oncology, Surgery +17

Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast.

Kai Chio Chan, W.F. Knox, Julia M.W. Gee et al. · PubMed · 2002 · 94 citations

Medicine, Oncology, Pharmacology +15

Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ

Kai Chio Chan, W.F. Knox, Guria Sinha et al. · Cancer · 2001 · 74 citations

Medicine, Surgery, Oncologic Surgery +16

Blockade of growth factor receptors in ductal carcinoma <i>in situ</i> inhibits epithelial proliferation

Kai Chio Chan, W.F. Knox, Ashu Gandhi et al. · British journal of surgery · 2001 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17